Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: September 26, 2022

Details for Patent: 7,018,656

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Summary for Patent: 7,018,656
Title:Antimycotic gel with high active substance release
Abstract:A pharmaceutical preparation comprising a hydrophilic gel-forming agent, water and a compound of the formula I ##STR00001## is suitable for the treatment and prophylaxis of dermatomycoses.
Inventor(s): Bohn; Manfred (Hofheim, DE), Kraemer; Karl Theodor (Langen, DE), Markus; Astrid (Liederbach, DE)
Assignee: Aventis Pharma Deutschland GmbH (Frankfurt am Main, DE)
Application Number:09/068,894
Patent Claim Types:
see list of patent claims
Composition; Compound;

Drugs Protected by US Patent 7,018,656

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,018,656

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany196 39 816Sep 27, 1996
PCT Information
PCT FiledSeptember 16, 1997PCT Application Number:PCT/EP97/05068
PCT Publication Date:April 02, 1998PCT Publication Number: WO98/13042

International Family Members for US Patent 7,018,656

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 008858 See Plans and Pricing
Austria 216882 See Plans and Pricing
Australia 4703797 See Plans and Pricing
Australia 718837 See Plans and Pricing
Bulgaria 103262 See Plans and Pricing
Bulgaria 63864 See Plans and Pricing
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.